Science ❯ Genetics

Gene Editing

CRISPR CRISPR Technology CRISPR/Cas9 Therapeutic Applications CRISPR-Cas9 Crispr Technology Genetic Engineering Xenotransplantation Research Animal Models Gene Doping Crispr Genetic Diversity Gene-Edited Meat Animal Biology De-extinction Gene Therapy Crispr-Cas9 Homology-Directed Repair DNA Replication Poc5 Protein Research Riboswitch Technology Xenotransplantation Techniques Therapeutic Proteins Recombinases Prime Editing System Recombinase Technology Prime Editor Components Reverse Transcription Process DNA-Based Parasite Colossal Biosciences

Lilly Strikes Up to $1.12 Billion Pact With Seamless Therapeutics for Hearing‑Loss Gene Editing

The pact centers on programmable recombinases for precise DNA changes independent of cellular repair.

POC5 Protein Proves Essential for Sperm Tail Assembly in Mouse Study

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

Small Subset of Newborn Liver Cells Drives Growth, Recasting Pediatric Gene Therapy Timing

CRISPR-Edited Snail Establishes First Model for Full Eye Regrowth

CRISPR Allelic-Drive Switch Renders Mosquitoes Unable to Transmit Malaria

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

IFN-γ Receptor Knockout Extends CAR-T Cell Lifespan and Boosts Tumor Combat